Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial

AIMS/INTRODUCTION: To assess the efficacy and safety of sitagliptin compared with α-glucosidase inhibitors in Japanese patients with type 2 diabetes inadequately controlled by metformin or pioglitazone alone. MATERIALS AND METHODS: In the present multicenter, randomized, open-label, parallel-group,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoh, Hidetaka, Kobayashi, Kazuki, Sato, Yasunori, Takemoto, Minoru, Uchida, Daigaku, Kanatsuka, Azuma, Kuribayashi, Nobuichi, Terano, Takashi, Hashimoto, Naotake, Sakurai, Kenichi, Hanaoka, Hideki, Ishikawa, Ko, Onishi, Shunichiro, Yokote, Koutaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364853/
https://www.ncbi.nlm.nih.gov/pubmed/25802726
http://dx.doi.org/10.1111/jdi.12282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364853/
https://www.ncbi.nlm.nih.gov/pubmed/25802726
http://dx.doi.org/10.1111/jdi.12282

Ejemplares similares